PMID- 22434086 OWN - NLM STAT- MEDLINE DCOM- 20120629 LR - 20211021 IS - 1945-7170 (Electronic) IS - 0013-7227 (Print) IS - 0013-7227 (Linking) VI - 153 IP - 5 DP - 2012 May TI - The ERbeta ligand 5alpha-androstane, 3beta,17beta-diol (3beta-diol) regulates hypothalamic oxytocin (Oxt) gene expression. PG - 2353-61 LID - 10.1210/en.2011-1002 [doi] AB - The endocrine component of the stress response is regulated by glucocorticoids and sex steroids. Testosterone down-regulates hypothalamic-pituitary-adrenal (HPA) axis activity; however, the mechanisms by which it does so are poorly understood. A candidate testosterone target is the oxytocin gene (Oxt), given that it too inhibits HPA activity. Within the paraventricular nucleus of the hypothalamus, oxytocinergic neurons involved in regulating the stress response do not express androgen receptors but do express estrogen receptor-beta (ERbeta), which binds the dihydrotestosterone metabolite 3beta,17beta-diol (3beta-diol). Testosterone regulation of the HPA axis thus appears to involve the conversion to the ERbeta-selective ligand 5alpha-androstane, 3beta-diol. To study mechanisms by which 3beta-diol could regulate Oxt expression, we used a hypothalamic neuronal cell line derived from embryonic mice that expresses Oxt constitutively and compared 3beta-diol with estradiol (E2) effects. E2 and 3beta-diol elicited a phasic response in Oxt mRNA levels. In the presence of either ligand, Oxt mRNA levels were increased for at least 60 min and returned to baseline by 2 h. ERbeta occupancy preceded an increase in Oxt mRNA levels in the presence of 3beta-diol but not E2. In tandem with ERbeta occupancy, 3beta-diol increased occupancy of the Oxt promoter by cAMP response element-binding protein and steroid receptor coactivator-1 at 30 min. At the same time, 3beta-diol led to the increased acetylation of histone H4 but not H3. Taken together, the data suggest that in the presence of 3beta-diol, ERbeta associates with cAMP response element-binding protein and steroid receptor coactivator-1 to form a functional complex that drives Oxt gene expression. FAU - Sharma, Dharmendra AU - Sharma D AD - Department of Pharmacology and Neuroscience and Institute for Aging and Alzheimer's Disease Research, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA. FAU - Handa, Robert J AU - Handa RJ FAU - Uht, Rosalie M AU - Uht RM LA - eng GR - R01 MH082900/MH/NIMH NIH HHS/United States GR - R01 NS039951/NS/NINDS NIH HHS/United States GR - R01-MH082900/MH/NIMH NIH HHS/United States GR - R01-NS039951/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20120320 PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 25126-76-5 (Androstane-3,17-diol) RN - 4TI98Z838E (Estradiol) RN - 50-56-6 (Oxytocin) SB - IM MH - Androstane-3,17-diol/metabolism/*pharmacology MH - Animals MH - Cell Line MH - Cells, Cultured MH - Estradiol/metabolism/pharmacology MH - Gene Expression/drug effects MH - Hypothalamus/*drug effects/metabolism MH - Mice MH - Neurons/*drug effects/metabolism MH - Oxytocin/*genetics/metabolism MH - Promoter Regions, Genetic/drug effects PMC - PMC3339641 EDAT- 2012/03/22 06:00 MHDA- 2012/06/30 06:00 PMCR- 2013/05/01 CRDT- 2012/03/22 06:00 PHST- 2012/03/22 06:00 [entrez] PHST- 2012/03/22 06:00 [pubmed] PHST- 2012/06/30 06:00 [medline] PHST- 2013/05/01 00:00 [pmc-release] AID - en.2011-1002 [pii] AID - EN-11-1002 [pii] AID - 10.1210/en.2011-1002 [doi] PST - ppublish SO - Endocrinology. 2012 May;153(5):2353-61. doi: 10.1210/en.2011-1002. Epub 2012 Mar 20.